World Neglected Tropical Diseases Day 2026 | 30 January

Jan 27, 2026 | Non classé

Neglected tropical diseases remain a daily reality for more than one billion people worldwide. Yet they are among the most solvable challenges in global health. With proven tools, coordinated action, and sustained commitment, NTDs can be prevented, treated, and eliminated.

Global progress shows what is possible. The number of people requiring NTD interventions has fallen significantly over the past decade, and dozens of countries have already achieved elimination of at least one disease. These milestones reflect the power of country-led programmes, innovation in diagnostics and treatment, and strong global partnerships.

However, this momentum cannot be taken for granted. Declining investment in global health threatens to slow, or undo, years of progress, particularly for communities most at risk. Continued action is essential to protect gains and advance toward the 2030 elimination goals.

At Pharmalys, we support efforts that strengthen health systems, improve access to effective interventions, and enable sustainable, locally owned NTD programmes. On World NTD Day, we reaffirm our commitment to collaboration, innovation, and evidence-based solutions that help ensure no disease, and no community, is left behind.

Source: World Health Organization, World NTD Day 2026 campaign page, https://www.who.int/campaigns/world-ntd-day/2026

Pharmalys corporate social responsibility commitments

Pharmalys corporate social responsibility commitments

Pharmalys’ approach to corporate social responsibility reflects its long-standing commitment to advancing clinical research while contributing to sustainable and inclusive healthcare systems, particularly across the African continent. Structured around three core...

A recap from the first Pharmalys Voice of 2026

A recap from the first Pharmalys Voice of 2026

On 26 March 26 2026, Pharmalys held its first Pharmalys Voice meeting of the year, bringing together colleagues from across the company for an engaging and interactive virtual session. With a mix of insightful presentations, lively discussions and moments of fun, the...

Women’s economic power benefits everyone

Women’s economic power benefits everyone

Gender equality is a core challenge to be met. More than 95% of women worldwide live in economies that do not provide full legal equality. Even in economies that have modernised their laws, women still face constraints that limit the work they can do, the businesses...

Microplastics and human health: A growing public health concern

Microplastics and human health: A growing public health concern

Developed following the 19th century Industrial Revolution, plastics are synthetic or semi-synthetic polymers, categorised according to the chemical composition of their primary polymer and any side chains. These include acrylics, polyesters, silicones, polyethylenes...

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

Jeanette Young’s unit at Pharmalys plays a crucial role in advancing global excellence in Good Clinical Laboratory Practice (GCLP) through the delivery of highly specialised ad hoc services, including tailored GCLP trainings and comprehensive gap analyses for...

Delivering excellence under complexity: Lessons learnt from Africa

Delivering excellence under complexity: Lessons learnt from Africa

Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the execution of numerous clinical trials (CTs) in Africa. Across these projects,...

Jeanette Young Shares GCLP Quality Insights with the TASK Team

Jeanette Young Shares GCLP Quality Insights with the TASK Team

On Friday 13 March 2026, Jeanette Young, Laboratory Solutions & GCLP Team Lead at Pharmalys, delivered an insightful and engaging presentation at TASK HQ  in South Africa. TASK is a global clinical research organisation with an in-house laboratory currently...